SkinBioTherapeutics adds interim CEO Rachel Parsonage to board
(Alliance News) - SkinBioTherapeutics on Monday confirmed the appointment of Interim Chief Executive Officer Rachel Parsonage to its board after completing regulatory due diligence. Read More